The Europe in vitro diagnostics market size is projected to exhibit a growth rate (CAGR) of 5.1% during 2024-2032. The increasing focus improving healthcare infrastructure, utilization of advanced technologies, escalating investment in healthcare by the public and private sectors, growing incidences of chronic illnesses, rising geriatric population, and shift towards personalized medicine represent some of the key factors driving the market.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2023
|
Forecast Years
|
2024-2032
|
Historical Years
|
2018-2023
|
Market Growth Rate 2024-2032 | 5.1% |
In vitro diagnostics (IVD) refers to a diverse array of medical tests and procedures conducted on human-derived samples, such as blood or tissue, to diagnose diseases, detect infections, monitor therapeutic drug applications, and pinpoint specific medical conditions. It includes immunochemistry, hematology, clinical chemistry, genetic testing, microbiology, and molecular diagnostics. IVD comprises various components, such as reagents, instruments, and specialized software, that are used across different healthcare environments. It is widely used in areas, such as healthcare, research laboratories, academic entities, pharmaceuticals, public health bodies, biotechnology firms, forensic science, veterinary applications, environmental assessments, and food and beverage (F&B) safety protocols. IVD aids in precise diagnosis, swift detection of diseases, stratification of patients for tailored treatment, planning of individualized treatment, elimination of unnecessary interventions, economic efficiency, and the amplification of overall healthcare effectiveness. In addition, it provides multiple advantages, such as heightened efficiency, pinpoint accuracy, steadfast reliability, promptness, scalability, flexibility, personalization, adherence to safety norms, conformity with regulatory mandates, active contribution to preventive healthcare measures, and the promotion of patient well-being and comfort.
The increasing focus on improving healthcare infrastructure by the European governments and regulatory bodies is propelling the market growth. Furthermore, the utilization of advanced technologies, such as artificial intelligence (AI) and machine learning (ML) in diagnostics to improve accuracy, reduce errors, and provide timely results is contributing to the market growth. Additionally, the escalating investment in healthcare by the public and private sectors to enhance diagnostic capabilities is strengthening the market growth. Apart from this, the growing incidences of chronic illnesses, such as diabetes and cardiovascular diseases (CVDs), which necessitate early and accurate diagnosis, are fueling the market growth. In addition, the rising geriatric population, which requires more extensive healthcare, including regular monitoring and testing, is catalyzing the market growth. Besides this, the shift towards personalized or precision medicine in Europe is facilitating the demand for more advanced diagnostic tools, such as IVD. Moreover, the heightened awareness among healthcare providers and patients about the importance of early diagnosis to prevent complications, reduce treatment costs, and enable timely intervention is positively impacting the market growth. Along with this, the rapid proliferation of private laboratories offering specialized testing services across Europe, thus enhancing accessibility to IVD, is favoring the market growth. In addition, the introduction of stringent regulations to ensure the safety, efficacy, and environmental sustainability of IVD products is bolstering the market growth.
IMARC Group provides an analysis of the key trends in each segment of the Europe in vitro diagnostics market report, along with forecasts at the regional and country levels for 2024-2032. Our report has categorized the market based on test type, product, usability, application, and end user.
Test Type Insights:
The report has provided a detailed breakup and analysis of the market based on the test type. This includes clinical chemistry, molecular diagnostics, immunodiagnostics, hematology, and others.
Product Insights:
The report has provided a detailed breakup and analysis of the market based on the product. This includes reagent and kits and instruments.
Usability Insights:
The report has provided a detailed breakup and analysis of the market based on usability. This includes disposable and reusable IVD devices.
Application Insights:
The report has provided a detailed breakup and analysis of the market based on application. This includes infectious disease, diabetes, cancer/oncology, cardiology, autoimmune disease, nephrology, and others.
End User Insights:
The report has provided a detailed breakup and analysis of the market based on end user. This includes hospitals laboratories, clinical laboratories, point-of-care testing centers, academic institutes, patients, and others.
Country Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include Germany, France, United Kingdom, Italy, Spain, and others.
The report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Report Features | Details |
---|---|
Base Year of the Analysis | 2023 |
Historical Period | 2018-2023 |
Forecast Period | 2024-2032 |
Units | US$ Billion |
Scope of the Report | Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
|
Test Types Covered | Clinical Chemistry, Molecular Diagnostics, Immunodiagnostics, Hematology, Others |
Products Covered | Reagent and Kits, Instruments |
Usabilities Covered | Disposable IVD Devices, Reusable IVD Devices |
Applications Covered | Infectious Disease, Diabetes, Cancer/Oncology, Cardiology, Autoimmune Disease, Nephrology, Others |
End Users Covered | Hospitals Laboratories, Clinical Laboratories, Point-of-care testing centers, Academic Institutes, Patients, Others |
Countries Covered | Germany, France, United Kingdom, Italy, Spain, Others |
Customization Scope | 10% Free Customization |
Report Price and Purchase Option | Single User License: US$ 3699 Five User License: US$ 4699 Corporate License: US$ 5699 |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |